These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37660283)

  • 21. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism.
    Eddington H; Chinnadurai R; Alderson H; Ibrahim ST; Chrysochou C; Green D; Erekosima I; Hutchison A; Bubtana A; Hegarty J; Kalra PA
    BMC Nephrol; 2021 Mar; 22(1):106. PubMed ID: 33757437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
    Liu Z; Su G; Guo X; Wu Y; Liu X; Zou C; Zhang L; Yang Q; Xu Y; Ma W
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010350. PubMed ID: 26376110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK.
    de Bruin IJA; Wyers CE; Souverein PC; van Staa TP; Geusens PPMM; van den Bergh JPW; de Vries F; Driessen JHM
    Osteoporos Int; 2020 Aug; 31(8):1487-1497. PubMed ID: 32266436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild hyperphosphatemia and mortality in hemodialysis patients.
    Rodriguez-Benot A; Martin-Malo A; Alvarez-Lara MA; Rodriguez M; Aljama P
    Am J Kidney Dis; 2005 Jul; 46(1):68-77. PubMed ID: 15983959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
    Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
    J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
    Block GA; Hulbert-Shearon TE; Levin NW; Port FK
    Am J Kidney Dis; 1998 Apr; 31(4):607-17. PubMed ID: 9531176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of normalized protein catabolic rate (nPCR) with the risk of bone fracture in patients undergoing maintenance hemodialysis: The Q-Cohort Study.
    Ohnaka S; Yamada S; Tsujikawa H; Arase H; Taniguchi M; Tokumoto M; Tsuruya K; Nakano T; Kitazono T
    Clin Nutr; 2021 Mar; 40(3):997-1004. PubMed ID: 32736816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.
    Lee JE; Lim JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Kwon E; Kim HJ; Park JM; Jung HY; Choi JY; Park SH; Kim CD; Cho JH; Kim YL;
    PLoS One; 2017; 12(10):e0185853. PubMed ID: 28973026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study.
    Wakasugi M; Kazama JJ; Wada A; Hamano T; Masakane I; Narita I
    Nephrol Dial Transplant; 2019 Jul; 34(7):1207-1216. PubMed ID: 30124993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study.
    Magagnoli L; Cozzolino M; Caskey FJ; Evans M; Torino C; Porto G; Szymczak M; Krajewska M; Drechsler C; Stenvinkel P; Pippias M; Dekker FW; de Rooij ENM; Wanner C; Chesnaye NC; Jager KJ;
    Nephrol Dial Transplant; 2023 Oct; 38(11):2562-2575. PubMed ID: 37230954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.
    Evenepoel P; Claes K; Meijers B; Laurent M; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D
    J Bone Miner Res; 2019 Feb; 34(2):262-269. PubMed ID: 30427544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function.
    Naylor KL; Prior J; Garg AX; Berger C; Langsetmo L; Adachi JD; Goltzman D; Kovacs CS; Josse RG; Leslie WD
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2032-2040. PubMed ID: 27797885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
    Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
    Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.
    Cozzolino M; Brancaccio D; Cannella G; Messa P; Gesualdo L; Marangella M; LoDeserto C; Pozzato M; Rombolà G; Costanzo AM; di Luzio Paparatti U; Mazzaferro S;
    Nephrol Dial Transplant; 2012 Sep; 27(9):3588-94. PubMed ID: 22523119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W; Chaiyakum A; Pongskul C
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex hormone-binding globulin is a biomarker associated with nonvertebral fracture in men on dialysis therapy.
    Aleksova J; Wong P; McLachlan R; Choy KW; Ebeling PR; Milat F; Elder GJ
    Kidney Int; 2018 Aug; 94(2):372-380. PubMed ID: 29776756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.